KKR to sell minority stake in Nordic Bioscience to company founder

KKR helped the business double its revenue and expand its capabilities across R&D services, clinical diagnostics and drug development.

3 September 2026•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.